vTv Therapeutics Inc. Cash and Cash Equivalents
vTv Therapeutics Inc. (VTVT) had Cash and Cash Equivalents of $86.64 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $86.64M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $98.09M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $88.93M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $98.50M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $86.64M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $98.09M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $88.93M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $98.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $25.92M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $31.06M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $36.75M 10-K · filed 2026-03-10 |
| 2024-09-30 | $41.57M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $45.53M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $52.26M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $9.45M 10-K · filed 2025-03-20 |
| 2023-09-30 | $8.24M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $12.60M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $18.77M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $12.13M 10-K · filed 2024-03-13 |
| 2022-09-30 | $15.34M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $17.86M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $12.14M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $13.41M 10-K · filed 2023-03-06 |
| 2021-09-30 | $19.57M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $10.84M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $8.45M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $5.75M 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.83M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.39M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $406.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.78M 10-K · filed 2021-02-24 |
| 2019-09-30 | $2.44M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $1.46M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $4.96M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.68M 10-K · filed 2020-02-21 |
| 2018-09-30 | $3.77M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.16M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $6.54M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $11.76M 10-K · filed 2019-02-26 |
| 2017-09-30 | $20.49M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $32.51M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $45.15M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $51.51M 10-K · filed 2018-02-27 |
| 2016-09-30 | $51.06M 10-Q · filed 2017-11-01 |
| 2016-06-30 | $63.84M 10-Q · filed 2017-08-02 |
| 2016-03-31 | $75.50M 10-Q · filed 2017-05-03 |
| 2015-12-31 | $88.00M 10-Q · filed 2017-11-01 |
| 2015-09-30 | $97.01M 10-Q · filed 2016-11-03 |
| 2015-06-30 | $2.40M 10-Q · filed 2016-08-02 |
| 2015-03-31 | $776.00K 10-Q · filed 2016-05-13 |
| 2014-12-31 | $1.38M 10-K · filed 2017-02-24 |
| 2014-09-30 | $1.04M 10-Q · filed 2015-11-13 |
| 2013-12-31 | $1.09M 10-K · filed 2017-02-24 |
| 2012-12-31 | $2.12M 10-K · filed 2016-03-04 |